Filtered By:
Management: Food and Drug Administration (FDA)

This page shows you your search results in order of relevance. This is page number 11.

Order by Relevance | Date

Total 5166 results found since Jan 2013.

Personalized Medicine: The Way Forward?
This article will look at some of the strategies already available to help healthcare professionals meet individual patient needs, in the multifaceted field of personalized medicine. Personalizing drug therapy for depression Research suggests that around 50 percent of patients with depression do not respond to first-line antidepressants. What can explain this, and how can it be solved? Current treatment is often a case of trial and error. A patient may take one medication after another, often for 12 weeks or more each time, while symptoms remain the same, or worsen. A team from King's College London in the United Kingd...
Source: Healthy Living - The Huffington Post - July 6, 2016 Category: Consumer Health News Source Type: news

FDA Cracks Down on Fake Mesothelioma Treatments
Stories abound of a “cancer-curing” tea from the forests of Canada. Herbal blends claim to “attack cancer at the DNA level.” For many years, mesothelioma patients have turned to alternative medicines like these as treatment options for the rare asbestos-related cancer. Sometimes these options are a last resort, after traditional treatments fail. They may be used in conjunction with standard treatment (complementary medicine) or on their own as the main approach. But the U.S. Food and Drug Administration (FDA) recently issued warning letters to companies that manufacture or market products claiming to prevent, di...
Source: Asbestos and Mesothelioma News - May 2, 2017 Category: Environmental Health Authors: Matt Mauney Tags: Alternative medicine Asparagus Extract BioStar Technology International Budwig Protocol cancer supplements cannabis oil cancer CellAssure Centers for Disease Control and Prevention Chelated Boron Circulatory Detox & Support Syrup compl Source Type: news

IJERPH, Vol. 19, Pages 2658: Over-the-Counter Medicine Attitudes and Knowledge among University and College Students in Brunei Darussalam: Findings from the First National Survey
This study aims to assess the knowledge, attitudes, and behaviour of students at institutions of higher learning in Brunei with regard to the safe use of OTC medicines. A cross-sectional study was performed using a self-administered online questionnaire, adapted from the literature with additional information from the United States Food and Drug Administration (FDA) on the educational resources in understanding OTC medicine for consumers. The questionnaire consisted of 4 sections: demographic information, knowledge of OTC medicines, attitudes, and practice. Descriptive and inferential statistics were used for data analysis...
Source: International Journal of Environmental Research and Public Health - February 24, 2022 Category: Environmental Health Authors: Ishpa Shapiah Abdullah Li Ling Chaw David Koh Zahid Hussain Khang Wen Goh Asma A ’tiyah Abdul Hamid Long Chiau Ming Tags: Article Source Type: research

U.S. FDA approves Foundation Medicine ’s FoundationOne®CDx as a companion diagnostic for Roche’s Rozlytrek® (entrectinib)
FoundationOneCDx can now be used to identify patients with ROS1 fusion-positive non-small cell lung cancer or patients with NTRK fusion-positive solidtumours for whom treatment withRozlytrek may be appropriateThis approval marks the first and only companion diagnostic indication forRozlytrek, and another important milestone intumour-agnostic approaches for people living with rare cancersRoche is a leader in drivingpersonalised healthcare around the world through validated diagnostic tools, genomic insights and a continued focus on drug developmentBasel, 9 June 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that ...
Source: Roche Media News - June 9, 2022 Category: Pharmaceuticals Source Type: news

Psychedelics May Be Part of U.S. Medicine Sooner Than You Think
It came as a surprise to many when, on Feb. 3, Australian regulators announced that medicines containing the psychedelic substances MDMA and psilocybin can soon be used there to treat post-traumatic stress disorder (PTSD) and treatment-resistant depression, respectively. That decision makes Australia the first country in the world to formally recognize the therapeutic use of psychedelics. Other countries, including the U.S., may be headed toward a similar outcome, some experts say. Research increasingly suggests that psychedelics can be powerful tools for treating a variety of mental-health conditions, from PTSD and depres...
Source: TIME: Health - February 8, 2023 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Drugs healthscienceclimate Source Type: news

Can Flush and Lock Solutions Used in Human Medicine Be Applied to Large Animal IV Therapy: A Systematic Review
Abstract: A recent shortage of prepackaged heparinized saline (HS) syringes has led to the question of whether or not normal saline (NS) can be used to both flush and lock IV catheters in large animal medicine (LAM). Moreover, several known medication incompatibilities exist with IV heparin administration. This is of particular concern in veterinary medicine where limited to no compatibility data exists between “veterinary only” (non-Food and Drug Administration approved) medications and heparin. Most of the literature on this subject is in human medicine where flushing of peripheral IV lines (PIVL) is done safely and ...
Source: Journal of Equine Veterinary Science - March 21, 2014 Category: Veterinary Research Authors: James Leonard, Tracy L. Skaer, Mark W. Garrison Tags: Review Articles Source Type: research

Review of the regulations for clinical research in herbal medicines in USA
Abstract In 2012, USA Food and Drug Administration (FDA) approved 39 new drugs, however, there are only two botanical drugs (one topical and one oral) approved by FDA since the publication of the FDA’s industry guidelines for the botanical drug product in June 2004. The approval shows the Western guideline can be used for herbal medicines, authors investigate current regulation on herbal medicine clinical research, identify challenges conducting clinical trials, and seek to produce some guidance for potential investigators and sponsors considering a clinical trial in this area. Key words were formulated for sea...
Source: Chinese Journal of Integrative Medicine - November 26, 2014 Category: Internal Medicine Source Type: research

Toward a prostate cancer precision medicine.
Abstract The promise of precision cancer medicine is that we will be able to pair clinical and genomic data to provide better and more efficient treatment for cancer care. Although the focus is on the optimal pairing of existing Food and Drug Administration-approved drugs with the patient׳s tumor, precision medicine should also help determine a patient׳s risk for disease progression. Precision medicine will hopefully also lead to improved molecular biomarkers. The specific needs for predictive biomarkers vary significantly based on cancer type. The chief aim for prostate cancer biomarker development is to help d...
Source: Urologic Oncology - November 20, 2014 Category: Urology & Nephrology Authors: Rubin MA Tags: Urol Oncol Source Type: research

Major achievements of evidence-based traditional Chinese medicine in treating major diseases.
This article also summarizes evidence-based traditional medicines and discusses quality control and quality assessment, the crucial steps in botanical drug development. Herbgenomics may provide effective tools to clarify the molecular mechanism of traditional medicines in the botanical drug development. The totality-of-the-evidence approach used by the U.S. Food and Drug Administration for botanical products provides the directions on how to perform quality control from the field throughout the entire production process. PMID: 28636884 [PubMed - as supplied by publisher]
Source: Biochemical Pharmacology - June 18, 2017 Category: Drugs & Pharmacology Authors: Chao J, Dai Y, Verpoorte R, Lam W, Cheng YC, Pao LH, Zhang W, Chen S Tags: Biochem Pharmacol Source Type: research

FDA and NIST collaboration on standards development activities supporting innovation and translation of regenerative medicine products
Publication date: Available online 18 May 2018 Source:Cytotherapy Author(s): Judith A. Arcidiacono, Steven R. Bauer, David S. Kaplan, Clare M. Allocca, Sumona Sarkar, Sheng Lin-Gibson The development of standards for the field of regenerative medicine has been noted as a high priority by several road-mapping activities. Additionally, the U.S. Congress recognizes the importance of standards in the 21st Century Cure Act. Standards will help to accelerate and streamline cell and gene therapy product development, ensure the quality and consistency of processes and products, and facilitate their regulatory approval. Although t...
Source: Cytotherapy - May 18, 2018 Category: Cytology Source Type: research

A Path Forward for Regenerative Medicine.
Abstract Although clinical trials of cell-based approaches to cardiovascular disease have yielded some promising results, no cell-based therapy has achieved regulatory approval for a cardiovascular indication. To broadly assess the challenges to regulatory approval and identify strategies to facilitate this goal, the Cardiac Safety Research Consortium sponsored a session during the Texas Heart Institute International Symposium on Cardiovascular Regenerative Medicine in September 2017. This session convened leaders in cardiovascular regenerative medicine, including participants from academia, the pharmaceutical ind...
Source: Circulation Research - August 3, 2018 Category: Cardiology Authors: Fanaroff AC, Morrow V, Krucoff MW, Seltzer JH, Perin EC, Taylor DA, Miller LW, Zeiher AM, Fernández-Avilés F, Losordo DW, Henry TD, Povsic TJ Tags: Circ Res Source Type: research

Enabling precision medicine via standard communication of HTS provenance, analysis, and results
by Gil Alterovitz, Dennis Dean, Carole Goble, Michael R. Crusoe, Stian Soiland-Reyes, Amanda Bell, Anais Hayes, Anita Suresh, Anjan Purkayastha, Charles H. King, Dan Taylor, Elaine Johanson, Elaine E. Thompson, Eric Donaldson, Hiroki Morizono, Hsinyi Tsang, Jeet K. Vora, Jeremy Goecks, Jianchao Yao, Jonas S. Almeida, Jonathon Keeney, KanakaDurga Addepalli, Konstantinos Krampis, Krista M. Smith, Lydia Guo, Mark Walderhaug, Marco Schito, Matthew Ezewudo, Nuria Guimera, Paul Walsh, Robel Kahsay, Srikanth Gottipati, Timothy C. Rodwell, Toby Bloom, Yuching Lai, Vahan Simonyan, Raja Mazumder A personalized approach based on a p...
Source: PLoS Biology: Archived Table of Contents - December 31, 2018 Category: Biology Authors: Gil Alterovitz Source Type: research

The Coronavirus Pandemic Is Creating a Drug Supply Crisis Just When We Most Need Medicine
As the world scrambles for a magic pharmaceutical bullet to stop the coronavirus, drugs perceived as cures – despite reed-thin evidence — have vanished from pharmacy shelves. Just last Friday, after President Trump touted the still unproven remedy of a malaria drug, hydroxychloroquine, the Food and Drug Administration lifted a restriction it had imposed on a Indian drug manufacturer with a record of manipulating its quality data, to allow it to make the active ingredient now suddenly in hot demand. With the United States long dependent on foreign drug manufacturers for low-cost medicine and key drug ingredients...
Source: TIME: Health - March 26, 2020 Category: Consumer Health News Authors: Katherine Eban Tags: Uncategorized COVID-19 Source Type: news